PRPH points higher, F rolls off lot, AH ailing

ProPhase Labs Inc. (NasdaqGM: PRPH) charged ahead in early afternoon trading Thursday, gaining 32.69 percent to $1.38. Volume was 25,509 shares, or more than four times its daily average. The drug company, based in Doylestown, Pa., Wednesday reported quarterly net sales of $5.20 million for the three months ended September 30, 2010, compared to net sales of $4.98 million for the prior-year quarter. PRPH realized quarterly net income of $947,000, or $0.06 per share, compared to net income of $1.2 million, or $0.09 per share, the year before.

Ford Motor Company (NYSE: F) sold widely Thursday, reporting volume in the early afternoon of 59,075,023 shares, compared to a full-day average of 69,745,000.  F shares stepped back 0.57 percent, though, to $16.55. Thursday, Ford Motor Co. Chief Executive Officer Alan Mulally said the company “deeply” appreciates the efforts by President Barack Obama and Ambassador Ron Kirk to negotiate a “meaningful” free trade agreement with Korea. Ford will continue to work closely with the Obama administration and Congress to fully open the Korean market to American-made cars and trucks.

Accretive Health Inc. (NYSE: AH) fared not so well in early Thursday afternoon trading, falling in price by 10.15 percent to $8.76. Volume in AH stock was 323,279 shares, compared to a daily average volume of 104,111 shares.  The Chicago-based company, which helps hospital systems manage their revenue cycles, said Thursday it turned a profit in the third quarter. AH said its net income totaled $2.9 million, or three cents per share. In the third quarter of 2009, the company distributed $8 million in dividends on preferred shares, and reported a loss of $3.8 million, or 11 cents per share. Its revenue rose 18 percent to $158.4 million from $134.5 million. However, analysts expected a profit of six cents per share and $172.4 million in revenue.

Tags: AH, consumer discretionary, F, healthcare, nasdaq, NYSE, pharmaceutical stocks, PRPH

This entry was posted on Thursday, November 11th, 2010 at 12:59 pm by Glenn and is filed under Consumer Discretionary Stocks, Health Care Stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.